Citation:Huh WK, Joura EA, Giuliano AR, Iversen OE, de Andrade RP, Ault KA, et al 2017
From National Cancer Control Policy
Huh WK, Joura EA, Giuliano AR, Iversen OE, de Andrade RP, Ault KA, et al. Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial. Lancet 2017 Nov 11;390(10108):2143-2159 Available from: http://www.ncbi.nlm.nih.gov/pubmed/28886907.
Critical appraisals